ISIN | LU1313772151 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Candriam Sustainable Equity Europe R |
Fund Provider |
CANDRIAM
Serenity, Bloc - B, 19-21, route d'Arlon 8009 Strassen E-Mail: CH@Candriam.com Phone: + 352 2797-1 Web: https://www.candriam.com |
Fund Provider | CANDRIAM |
Representative in Switzerland |
CACEIS Bank, Montrouge, Zurich Branch / Switzerland Zurich Phone: +41 44 405 97 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The aim of the Sub-Fund is to enable shareholders to benefit from the growth of the European equity markets with an investment in equities selected by the portfolio management team on a discretionary basis and to outperform the benchmark. The selection is based on the stocks characteristics and growth prospects, as well as proprietary analysis of ESG criteria. |
Peculiarities |
Current Price * | 173.53 EUR | 21.11.2024 |
---|---|---|
Previous Price * | 173.05 EUR | 20.11.2024 |
52 Week High * | 187.58 EUR | 27.09.2024 |
52 Week Low * | 162.49 EUR | 28.11.2023 |
NAV * | 173.53 EUR | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 831,324,968 | |
Unit/Share Assets *** | 10,973,669 | |
Trading Information SIX |
YTD Performance | +0.82% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +0.85% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -4.89% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -4.72% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -5.22% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +7.31% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +6.30% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | -4.87% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | -1.51% |
23.09.2021 - 21.11.2024
23.09.2021 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
KBC Groupe NV | 4.13% | |
---|---|---|
ASML Holding NV | 3.22% | |
Roche Holding AG | 3.11% | |
Novartis AG Registered Shares | 3.09% | |
Dassault Systemes SE | 3.03% | |
FinecoBank SpA | 2.97% | |
Reckitt Benckiser Group PLC | 2.64% | |
Beiersdorf AG | 2.62% | |
AstraZeneca PLC | 2.61% | |
Kerry Group PLC Class A | 2.53% | |
Last data update | 30.09.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | 1.01% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |